Filing Flows

Filing Flows › Companies › Globus Medical › Cash flow

Globus Medical cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$225M in Q3 2026 · $767M over twelve months

Operating cash flow$265M
Capital spending−$40.4M
Free cash flow+$225M
Cash / net income1.9×
Cash conversion cycle363 days

Analysis

In Q3 2026, Globus Medical generated $265M of operating cash flow and spent $40.4M on capital projects, leaving free cash flow of $225M. That is $11.0M more than in Q3 2025 ($214M).

Over the twelve months to Sep 30, 2026, operating cash flow was $926M; the largest uses were other investing ($407M), buybacks ($324M), capital spending ($159M); besides operations, cash came from shares issued ($116M); the cash balance rose by $116M.

Operating cash flow was $265M against net income of $141M — 1.9× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$70.4M, accrued liabilities +$20.4M, inventory −$15.5M.

Its cash conversion cycle was 363 days (receivables 82 + inventory 323 − payables 42).

Free cash flow

Globus Medical: free cash flow by quarterGlobus Medical: free cash flow by quarter$193MQ4 2024$141MQ1 2025$31.3MQ2 2025$214MQ3 2025$202MQ4 2025$163MQ1 2026$177MQ2 2026$225MQ3 2026
Operating cash flow less capital spending.
Globus Medical: operating cash flow against capital spendingGlobus Medical: operating cash flow against capital spendingOperating cash flowCapital spending$210M$17.1MQ4 2024$177M$36.1MQ1 2025$77.9M$46.6MQ2 2025$250M$35.8MQ3 2025$249M$46.2MQ4 2025$202M$39.6MQ1 2026$210M$33.2MQ2 2026$265M$40.4MQ3 2026
Latest (Q3 2026): Operating cash flow $265M, Capital spending $40.4M.

Capital allocation, year by year

Globus Medical: where the cash came from (up) and went (down), by fiscal yearGlobus Medical: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingAcquisitionsBuybacksFY2021: Operating cash flow $276MFY2021: Shares issued $63.5MFY2021: Capital spending −$56.9MFY2021: Acquisitions −$34.5M$340MFY2021FY2022: Operating cash flow $178MFY2022: Shares issued $41.7MFY2022: Capital spending −$74.0MFY2022: Acquisitions −$31.4MFY2022: Buybacks −$144M$220MFY2022FY2023: Operating cash flow $243MFY2023: Net borrowing −$913KFY2023: Shares issued $12.4MFY2023: Capital spending −$78.3MFY2023: Acquisitions −$296MFY2023: Buybacks −$226M$256MFY2023FY2024: Operating cash flow $521MFY2024: Net borrowing −$1.0MFY2024: Shares issued $110MFY2024: Capital spending −$115MFY2024: Acquisitions −$17.6MFY2024: Buybacks −$85.8M$631MFY2024FY2025: Operating cash flow $753MFY2025: Net borrowing −$450MFY2025: Shares issued $89.8MFY2025: Capital spending −$165MFY2025: Acquisitions −$253MFY2025: Buybacks −$300M$843MFY2025
Over these 5 years operating cash flow totalled $2.0B; the largest uses were buybacks ($756M) and acquisitions ($632M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$517M
Debtnone
Net cash$517M

Globus Medical funds itself: free cash flow was $767M over the last twelve months, with $517M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Globus Medical: sources (+) and uses (−) of cash, Q3 2026Globus Medical: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$265MBuybacks−$143MOther investing−$99.5MCapital spending−$40.4MCash drawn (+) / kept (−)$20.1MAcquisitions−$16.0MShares issued$15.9MOther financing−$3.6MExchange rates$1.4MNet borrowing (+) / repaid (−)−$85K
Globus Medical: sources (+) and uses (−) of cash, TTM to Q3 2026Globus Medical: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow$926MOther investing−$407MBuybacks−$324MCapital spending−$159MCash drawn (+) / kept (−)−$116MShares issued$116MOther financing−$21.3MAcquisitions−$12.8MTaxes on employees’ shares−$3.7MExchange rates$2.9MNet borrowing (+) / repaid (−)−$432K

From profit to cash

Globus Medical: net income to operating cash flow, Q3 2026Globus Medical: net income to operating cash flow, Q3 2026Net income$141MDepreciation & amortization$70.4MStock-based pay$11.7MDeferred taxes$9.0MGains on disposals$1.2MReceivables$14.9MInventory−$15.5MPayables$1.3MAccrued liabilities$20.4MPrepaid and other assets$4.3MIncome taxes payable−$1.8MOperating cash flow$265M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 20268232342363
Q2 20267929840338
Q1 20268129539336
Q4 20257227033309
Q3 20257428132323
Q2 20257026329303
Q1 20258230534353
Q4 20248024023297

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$265M−$40.4M−$16.0M−$143M−$85K$15.9M$20.1M$225M
Q2 2026$210M−$33.2M−$1.5M−$136M−$81K$11.0M$53.2M$177M
Q1 2026$202M−$39.6M−$4.9M—−$88K$26.0M−$34.8M$163M
Q4 2025$249M−$46.2M$9.7M−$45.0M−$178K$62.8M−$154M$202M
Q3 2025$250M−$35.8M−$4.7M−$40.0M−$17K$11.1M−$142M$214M
Q2 2025$77.9M−$46.6M−$253M−$25.0M−$82K$4.7M$232M$31.3M
Q1 2025$177M−$36.1M−$5.0M−$190M−$450M$11.2M$323M$141M
Q4 2024$210M−$17.1M—−$1.0M−$58K$69.3M−$162M$193M

Globus Medical: income statement and cash flow

Globus Medical, Q3 2026: revenue $764M (-0.7% year over year), operating margin 23.2%. The chart follows the revenue to costs, profit and cash.

Globus Medical: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.